Axel Mark
3624
Renascience
4889
Ecomott
3987
Festaria Holdings
2736
Tecnisco
2962
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.50%8.79B | 8.61%37.12B | 5.23%9.54B | 8.31%9.48B | 13.48%9.44B | 7.73%8.66B | 20.85%34.17B | 17.62%9.07B | 30.67%8.75B | 27.58%8.32B |
Cost of revenue | -1.15%4.83B | 5.99%21.08B | 7.80%5.58B | 6.14%5.13B | 13.71%5.48B | -3.34%4.89B | 17.64%19.89B | 3.93%5.18B | 22.04%4.83B | 26.28%4.82B |
Gross profit | 4.94%3.95B | 12.26%16.04B | 1.78%3.96B | 10.95%4.35B | 13.24%3.97B | 26.51%3.77B | 25.64%14.29B | 42.69%3.89B | 43.20%3.92B | 29.34%3.51B |
Operating expense | 9.20%3.15B | 10.39%12.62B | 12.51%3.39B | 11.05%3.1B | 14.16%3.25B | 3.56%2.88B | 10.86%11.43B | 12.88%3.01B | 10.90%2.79B | 10.91%2.85B |
Staff costs | 15.58%942M | 11.55%4.45B | 12.88%1.82B | 14.39%914M | 8.94%902M | 8.52%815M | 18.21%3.99B | 16.52%1.62B | 20.15%799M | 23.21%828M |
Selling and administrative expenses | ---- | 10.99%2.25B | ---- | ---- | ---- | ---- | 19.13%2.03B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 20.80%871M | ---- | ---- | ---- | ---- | 28.98%721M | ---- | ---- | ---- |
-General and administrative expense | ---- | 5.58%1.38B | ---- | ---- | ---- | ---- | 14.32%1.31B | ---- | ---- | ---- |
Research and development costs | 7.96%976M | 2.59%3.96B | 3.16%1.04B | 11.29%986M | 4.47%1.03B | -7.76%904M | -1.76%3.86B | 2.22%1.01B | -4.01%886M | 0.92%984M |
Depreciation and amortization | ---- | 33.85%257M | ---- | ---- | ---- | ---- | 15.66%192M | ---- | ---- | ---- |
-Depreciation | ---- | 33.85%257M | ---- | ---- | ---- | ---- | 15.66%192M | ---- | ---- | ---- |
Other operating expenses | 5.68%1.23B | 25.00%1.69B | -8.23%-1.99B | 8.44%1.2B | 27.54%1.32B | 10.57%1.16B | 19.65%1.35B | -16.43%-1.84B | 19.14%1.1B | 12.50%1.04B |
Operating profit | -8.93%806M | 19.74%3.42B | -35.28%565M | 10.70%1.25B | 9.27%719M | 353.85%885M | 169.02%2.86B | 1,516.67%873M | 407.17%1.13B | 360.14%658M |
Net non-operating interest income (expenses) | 51.11%68M | 20.00%192M | 43.75%46M | -2.00%49M | 23.81%52M | 25.00%45M | 119.18%160M | 88.24%32M | 150.00%50M | 133.33%42M |
Non-operating interest income | 51.11%68M | 21.25%194M | 50.00%48M | -2.00%49M | 23.81%52M | 25.00%45M | 119.18%160M | 88.24%32M | 150.00%50M | 133.33%42M |
Non-operating interest expense | ---- | --2M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net investment income | -3.90%444M | 217.95%744M | 588.24%351M | 40.71%-268M | 12.43%199M | 0.87%462M | -34.82%234M | -76.50%51M | -526.42%-452M | 17,800.00%177M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 150.00%15M | 200.00%3M | 2M | 200.00%3M | 75.00%7M | 107.50%6M | -50.00%1M | 0 | -66.67%1M |
Income from associates and other participating interests | 0 | 0 | 0 | -185.71%-20M | -300.00%-8M | -140.00%-4M | 16.67%-5M | |||
Special income (charges) | 11M | |||||||||
Less:Restructuring and mergern&acquisition | ---11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -116.22%-18M | 51.61%47M | -2,550.00%-53M | -153.85%-7M | -166.67%-4M | 692.86%111M | -61.25%31M | -113.33%-2M | -67.50%13M | -50.00%6M |
Income before tax | -13.11%1.31B | 35.38%4.42B | -3.40%909M | 39.24%1.03B | 10.13%968M | 114.79%1.51B | 119.81%3.26B | 214.72%941M | 135.35%739M | 417.06%879M |
Income tax | 0.54%374M | 38.86%954M | -73.96%25M | 32.37%274M | 22.51%283M | 143.14%372M | 76.15%687M | 536.36%96M | 41.78%207M | 185.19%231M |
Net income | -17.59%937M | 34.46%3.46B | 4.62%884M | 41.92%755M | 5.71%685M | 107.10%1.14B | 135.50%2.57B | 163.24%845M | 218.56%532M | 628.09%648M |
Net income continuous operations | -17.57%938M | 34.45%3.46B | 4.62%884M | 41.92%755M | 5.71%685M | 106.91%1.14B | 135.37%2.58B | 163.24%845M | 216.67%532M | 628.09%648M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -17.59%937M | 34.46%3.46B | 4.62%884M | 41.92%755M | 5.71%685M | 107.10%1.14B | 135.50%2.57B | 163.24%845M | 218.56%532M | 628.09%648M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -17.59%937M | 34.46%3.46B | 4.62%884M | 41.92%755M | 5.71%685M | 107.10%1.14B | 135.50%2.57B | 163.24%845M | 218.56%532M | 628.09%648M |
Gross dividend payment | ||||||||||
Basic earnings per share | -17.57%65.35 | 34.45%241.19 | 4.62%61.58 | 41.95%52.62 | 5.69%47.71 | 106.89%79.28 | 135.36%179.39 | 163.00%58.86 | 217.38%37.07 | 630.42%45.14 |
Diluted earnings per share | -17.57%65.35 | 34.45%241.19 | 4.62%61.58 | 41.92%52.6043 | 5.69%47.71 | 106.89%79.28 | 135.36%179.39 | 163.18%58.86 | 218.56%37.0659 | 630.42%45.14 |
Dividend per share | 0 | 34.72%97 | 53.19%72 | 0 | 0.00%25 | 0 | 44.00%72 | 88.00%47 | 0 | 0.00%25 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |